Longevity · Longevity peptide (research)
NAD+
- Drug class
- Longevity peptide (research)
- Status
- Compounded (503A)
- Also known as
- nad, nad plus, nicotinamide adenine dinucleotide, nmn, nr, nicotinamide
- Reviewed
- 2026-06-01 · Kindr Health Clinical Team
What NAD+ is studied for
- Mitochondrial energy (research)
- Cellular repair (research)
- Cognitive clarity (research)
Mechanism of action
NAD+ is being studied in the longevity category. Coenzyme essential to mitochondrial energy and cellular repair. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.
Frequently asked questions
What is NAD+?
NAD+ is a longevity peptide. Coenzyme essential to mitochondrial energy and cellular repair.
What is NAD+ studied for?
Published research has examined NAD+ for mitochondrial energy, cellular repair, cognitive clarity. Human clinical evidence varies by indication.
Is NAD+ FDA-approved?
No. NAD+ is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.
How is NAD+ used in research?
Protocols vary by study. NAD+ is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.
What are the known risks?
Long-term human safety data for NAD+ is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.
Build the NAD+ protocol stack
Research protocols commonly pair NAD+ with the peptides below. Add all three vials to unlock the bundle discount at checkout.
Related peptides in Longevity
Continue across the Kindr entity graph
Related evidence, peptides, and clinical tools on the same topic.